Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neuroblastoma 3Leukemia 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Thrombocytopenia 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Glioblastoma 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

fludarabine phosphate 4Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Filgrastim 3Cyclosporine 3fludarabine 2Whole-Body Irradiation 2Thiotepa 2Methylprednisolone 2Methotrexate 2Melphalan 2Cytarabine 2trametinib 1Stem Cell Transplantation 1Specimen Handling 1Sorafenib 1Sirolimus 1Mitoxantrone 1Methylprednisolone Hemisuccinate 1Isotretinoin 1Injections 1Granulocyte Colony-Stimulating Factor 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Myelomonocytic, Juvenile × Isotretinoin × Clear all
NCT00609739 2017-12-28

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

Masonic Cancer Center, University of Minnesota

Phase 1/2 Terminated
1 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡